- By Joe Dangor
The American Society of Hematology recognizes Stephen Ansell, M.D. of Mayo Clinic with the 2021 Ernest Beutler Lecture and Prize
ROCHESTER, Minn. — The American Society of Hematology (ASH) has recognized Stephen Ansell, M.D., of Mayo Clinic with the highly distinguished Ernest Beutler Lecture and Prize as part of its Honorific Awards to recognize exemplary hematologists who have made significant contributions to the field and have been nominated by ASH members.
Dr. Ansell, a hematologist in the Department of Medicine at the Mayo Clinic and a distinguished leader in the Mayo Clinic Comprehensive Cancer Center in Rochester, Minnesota, was recognized as the translational/clinical awardee for his work on understanding the tumor microenvironment in lymphoma and for developing treatment strategies that block inhibitory signals or deplete suppressive cells to eradicate cancer.
“This is a tremendous and richly deserved honor for Dr. Ansell,” says Cheryl Willman, M.D., executive director of Mayo Clinic Cancer Programs and director of Mayo Clinic Comprehenisve Cancer Center. “We could not be more proud of Dr. Ansell and his discoveries of novel treatment approaches for patients with lymphoma.”
Dr. Ansell shares the Ernest Beutler Lecture and Prize with Margaret Shipp, M.D., of Dana Farber/Harvard Cancer Center. According to the American Society of Hematology, Drs. Ansell and Shipp have brought their breakthroughs in understanding the lymphoma tumor cellular environment out of the research lab and into the lives of patients through more effective immunotherapies.
Named for the late Dr. Ernest Beutler, a past president of ASH and physician-scientist for more than 50 years, this two-part lectureship is intended to recognize major translational advances related to a single topic. Each year, ASH presents this award to two individuals: one who has enabled advances in basic science and one for achievements in clinical science or translational research.
The awards will be presented during the 63rd ASH Annual Meeting, Dec. 11–14.
About Mayo Clinic Cancer Center
Designated as a comprehensive cancer center by the National Cancer Institute, Mayo Clinic Cancer Center is defining new boundaries in possibility, focusing on patient-centered care, developing novel treatments, training future generations of cancer experts, and bringing cancer research to communities. At Mayo Clinic Cancer Center, a culture of innovation and collaboration is driving research breakthroughs that are changing approaches to cancer prevention, screening and treatment, and improving the lives of cancer survivors.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news. For information on COVID-19, including Mayo Clinic's Coronavirus Map tracking tool, which has 14-day forecasting on COVID-19 trends, visit the Mayo Clinic COVID-19 Resource Center.
- Joe Dangor, Mayo Clinic Public Affairs, email@example.com